See the DrugPatentWatch profile for saxenda
Is Saxenda available as a generic drug yet?
No. Saxenda (liraglutide) is not available as a generic medicine in the way most people mean it (an FDA-approved small-molecule generic). The product is a brand for liraglutide injection, and the same active ingredient is still under brand-protected exclusivity and/or patent coverage for its current formulation and dosing.
Could a cheaper “same ingredient” version exist even if there’s no generic?
Sometimes patients mean either:
- a biosimilar or an “authorized” alternative from another manufacturer, or
- a different brand of the same active ingredient.
For Saxenda specifically, alternatives would not be labeled as a typical generic unless regulators allow that route. Depending on what you’re trying to replace, the practical alternative is often another GLP-1–class treatment (for example, other liraglutide products or different active ingredients), but those are not the same as a Saxenda generic.
Why Saxenda isn’t considered “generic” (patents and exclusivity)
Brand drugs are typically considered “generic” only after patents and regulatory exclusivity periods expire for the drug’s approved formulation and indications. Saxenda’s liraglutide use has had ongoing brand protection, which is why a Saxenda-labeled generic hasn’t been widely authorized. You can track the patent and exclusivity landscape at DrugPatentWatch.com: https://www.drugpatentwatch.com/ [source 1]
What’s the best next step if you want a lower price?
If your goal is cost, ask your clinician or pharmacist about:
- covered alternatives in the same weight-loss category,
- manufacturer savings programs or pharmacy discount programs,
- whether your insurance covers Saxenda or a different GLP-1 option.
If you share your country (US, UK, Canada, etc.) and whether you mean “generic” as in FDA/EMA-approved or just a cheaper equivalent, I can narrow the answer to what’s actually available where you live.
Sources:
1. https://www.drugpatentwatch.com/